Heimann, M.; Elashry, M.I.; Klymiuk, M.C.; Eldaey, A.; Wenisch, S.; Arnhold, S.
Optimizing the Adipogenic Induction Protocol Using Rosiglitazone Improves the Physiological Parameters and Differentiation Capacity of Adipose Tissue-Derived Mesenchymal Stem Cells for Horses, Sheep, Dogs, Murines, and Humans. Animals 2023, 13, 3224.
https://doi.org/10.3390/ani13203224
AMA Style
Heimann M, Elashry MI, Klymiuk MC, Eldaey A, Wenisch S, Arnhold S.
Optimizing the Adipogenic Induction Protocol Using Rosiglitazone Improves the Physiological Parameters and Differentiation Capacity of Adipose Tissue-Derived Mesenchymal Stem Cells for Horses, Sheep, Dogs, Murines, and Humans. Animals. 2023; 13(20):3224.
https://doi.org/10.3390/ani13203224
Chicago/Turabian Style
Heimann, Manuela, Mohamed I. Elashry, Michele C. Klymiuk, Asmaa Eldaey, Sabine Wenisch, and Stefan Arnhold.
2023. "Optimizing the Adipogenic Induction Protocol Using Rosiglitazone Improves the Physiological Parameters and Differentiation Capacity of Adipose Tissue-Derived Mesenchymal Stem Cells for Horses, Sheep, Dogs, Murines, and Humans" Animals 13, no. 20: 3224.
https://doi.org/10.3390/ani13203224
APA Style
Heimann, M., Elashry, M. I., Klymiuk, M. C., Eldaey, A., Wenisch, S., & Arnhold, S.
(2023). Optimizing the Adipogenic Induction Protocol Using Rosiglitazone Improves the Physiological Parameters and Differentiation Capacity of Adipose Tissue-Derived Mesenchymal Stem Cells for Horses, Sheep, Dogs, Murines, and Humans. Animals, 13(20), 3224.
https://doi.org/10.3390/ani13203224
